Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 4/12/2019
SIETES contiene 92848 citas

 
 
 1 a 20 de 118 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, Seeff LB, Serrano J, Sherker AH, Stolz A, Talwalkar J, Vega M, Vuppalanchi R. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014;60:1399-408. [Ref.ID 97869]
2.Enlace a cita original Cita con resumen
Feliz J. National study: teens report higher use of performance enhancing substances. Partnership for drug-free kids 2014:22 de julio. [Ref.ID 97750]
3. Cita con resumen
Evans-Brown M, Kimergård A, McVeigh J, Chandler M, Brandt SD. Is tamoxifen being sold to bodybuilders?. BMJ 2014;348:g1476. [Ref.ID 97330]
4.Enlace a cita original
Heuberger JAAC, Tervaert JMC, Schepers FML, Vliegenthart ADB, Rotmans JI, Daniels JMA, Burggraaf J, Cohen AF. Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit. Br J Clin Pharmacol 2013;75:1406-21. [Ref.ID 95567]
6.Tiene citas relacionadas Cita con resumen
Rane A, Ekström L. Androgens and doping tests: genetic variation and pit-falls. Br J Clin Pharmacol 2012;74:3-15. [Ref.ID 93372]
7.Tiene citas relacionadas
Ritter JM. Sex, steroids and anabolic androgens in athletics. Br J Clin Pharmacol 2012;74:1-2. [Ref.ID 93371]
8. Cita con resumen
Anónimo. Méthylphénidate: abus et dépendances. Prescrire 2012;32:428. [Ref.ID 93120]
9.
Senard-Ojero A, Durrieu G, Depiesse F, Schmitt L, Riviere D, Montastruc J-L. Consommation de substances interdites chez le sportif: étude à l'Antenne Médicale de Prévention du Dopage de Midi-Pyrénées (AMPD-MP). Therapie 2010;65:459-63. [Ref.ID 89879]
10.
Sugden C, Aggarwal R, Housden C, Sahakian BJ, Darzi A. Pharmacological enhancement of performance in doctors. BMJ 2010;341:261-2. [Ref.ID 89031]
11.
Sabio García E, Navarro Vidal B, Panadero Carlavilla FJ. Dopaje. PAM 2009;33:903-14. [Ref.ID 87107]
12.Tiene citas relacionadas
Palacios Gil-Antuñano N, Iglesias-Gutiérrez E, Úbeda Martín N. Efecto de la cafeína en el rendimiento deportivo. Med Clin (Barc) 2009;10:20-4. [Ref.ID 85861]
13.Tiene citas relacionadas Cita con resumen
Evans-Brown M, Dawson R, McVeigh J. The dire consequences of doping?. Lancet 2008;372:1544. [Ref.ID 84344]
14.Tiene citas relacionadas Cita con resumen
Gerber PA, Kukova G, Meller S, Neumann NJ, Homey B. The dire consequences of doping. Lancet 2008;372:656. [Ref.ID 83787]
15.
Kayser B, Smith ACT. Globalisation of anti-doping: the reverse side of the medal. BMJ 2008;337:85-7. [Ref.ID 83528]
16. Cita con resumen
Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008;371:1872-82. [Ref.ID 83085]
17.
Liu H, Bravata DM, Olkin I, Friedlander A, Liu V, Roberts B, Bendavid E, Saynina O, Salpeter SR, Garber AM, Hoffman AR. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med 2008;148:747-58. [Ref.ID 82998]
19.Enlace a cita original Cita con resumen
Kmietowicz Z. Tough measures are needed to tackle doping in sport, say MPs. BMJ 2007;334:387. [Ref.ID 79359]
20. Cita con resumen
Anónimo. Swissmedic warns bodybuilders about somatropin misuse. Scrip 2006;3122:8. [Ref.ID 75900]
Seleccionar todas
 
 1 a 20 de 118 siguiente >>